BlackRock Health Sciences Term (BMEZ) vs Oaktree Specialty Lending (OCSL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BlackRock Health Sciences Term (BMEZ) has outperformed Oaktree Specialty Lending (OCSL) over the past year, gaining 8.4% versus a loss of 6.8%. Over five years, BMEZ leads with a -40.5% price change compared with -46.7% for OCSL. Oaktree Specialty Lending is the larger company by market cap ($1.04 billion vs $1.02 billion), about 1.0 times the size.
On valuation, BlackRock Health Sciences Term trades at a lower trailing P/E (4.8x vs 24.6x for Oaktree Specialty Lending). Oaktree Specialty Lending pays a dividend yielding 12.72%, while BlackRock Health Sciences Term does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEZ | OCSL |
|---|---|---|
| Share price | $16.26 | $11.79 |
| Market cap | $1.02B | $1.04B |
| 1-day change | -1.63% | +1.20% |
| YTD return | +8.04% | -7.46% |
| 1-year return | +8.40% | -6.80% |
| 5-year return | -40.53% | -46.68% |
| P/E ratio (TTM) | 4.80 | 24.56 |
| Forward P/E | — | 8.66 |
| EPS (TTM) | $3.39 | $0.48 |
| Dividend yield | 7.99% | 12.72% |
| Annual dividend | $0.00 | $1.50 |
| 52-week high | $17.25 | $14.31 |
| 52-week low | $13.70 | $10.63 |
| Distance from 52-week high | -5.74% | -17.61% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +6.02% |
| Average volume | 141.75K | 493.51K |
| Shares outstanding | 62.50M | 88.09M |
| Sector | Finance | Finance |
| Industry | Trusts Except Educational Religious and Charitable | Finance: Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BMEZ has outperformed OCSL by 15.2 percentage points over the past year.
- Oaktree Specialty Lending trades at a higher earnings multiple (24.6x vs 4.8x trailing P/E).
- Oaktree Specialty Lending offers a meaningfully higher dividend yield (12.72% vs 7.99%).
About Oaktree Specialty Lending
OCSL stock →Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies.
Finance · Finance: Consumer Services
BMEZ vs OCSL FAQ
Which is bigger, BlackRock Health Sciences Term or Oaktree Specialty Lending?
Oaktree Specialty Lending (OCSL) is larger, with a market capitalization of $1.04B compared with $1.02B for BlackRock Health Sciences Term (BMEZ).
Which stock has performed better over the past year, BMEZ or OCSL?
BMEZ returned +8.40% over the past 12 months, compared with -6.80% for OCSL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BMEZ or OCSL?
BMEZ has the lower trailing P/E at 4.8, versus 24.6 for OCSL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, BlackRock Health Sciences Term or Oaktree Specialty Lending?
Oaktree Specialty Lending has the higher yield at 12.72%, compared with 7.99% for BlackRock Health Sciences Term.
Are BlackRock Health Sciences Term and Oaktree Specialty Lending in the same industry?
Both are in the Finance sector, but in different industries: Trusts Except Educational Religious and Charitable for BlackRock Health Sciences Term and Finance: Consumer Services for Oaktree Specialty Lending.